Professor Andrew Ewer MB ChB, MD, MRCP, FRCPCH

• MD – University of Birmingham 1998
• Fellowship of Royal College of Paediatrics and Child Health 1996
• Membership to the Royal College of Physicians 1989
• MBChB – University of Birmingham 1985

Andrew Ewer qualified with a MBChB in Medicine and Surgery from the University of Birmingham in 1985. He trained in paediatrics in Birmingham and Sheffield and gained MRCP in 1989. He won a Sheldon Research Training Fellowship in 1991 and investigated gastric emptying and gastro-oesophageal reflux in preterm infants. Following this, in 1994 he won a fellowship to Monash Medical Centre in Melbourne, Australia and continued his clinical training and research there.

He returned to the University of Birmingham as Lecturer in Neonatal Paediatrics and was awarded FRCPCH in 1997 and an MD degree from the University of Birmingham in 1998. He was appointed as Senior Research Fellow and Honorary Consultant Neonatologist at Birmingham Women’s Hospital. He was appointed Senior Lecturer at the University of Birmingham in 2009, Reader in Neonatal Paediatrics in 2012 and Professor of Neonatal Medicine in 2015.

His research interests include: newborn screening, neonatal gastrointestinal function (particularly gastric function and necrotising enterocolitis), neonatal cardiology and perinatal clinical trials.

He is an invited referee for 22 peer-reviewed journals and is an associate editor of the journal Archives of Disease in Childhood Fetal and Neonatal Edition. He is President elect of the UK Neonatal Society and a past member of two national clinical studies groups; the Intrapartum Care CSG and the MCRN/AMR CSG. He is a member of the Trial Steering Committee for six national clinical trials.

In 2011 he was invited as an advisor to the United States Health Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children workgroup on Screening for Critical Congenital Cyanotic Heart Disease. Screening was subsequently endorsed by the US Health Secretary and is being implemented as national policy. Since 2012, he has been an advisor to the Newborn and Infant Physical Examination group on the UK National Screening Committee (NSC) and was a board member of the NSC pulse oximetry screening pilot programme, which began in 2015.

Since 2015, he has been College Impact Lead for the College of Medical and Dental Sciences, leading the College's REF Impact submission.

Teaching Programmes

• MBChB
• Year 2 – Module on temperature regulation in newborns
• Year 5 – Coordinator of neonatology teaching
• Examiner for final year paediatrics

Andrew has supervised PhD and MD postgraduate students in laboratory and clinical research.

Research themes

Newborn screening, neonatal gastrointestinal function (particularly gastric function and necrotising enterocolitis), neonatal cardiology and clinical trials.

Research activity

Gastrointestinal function in preterm infants

i) Gastric emptying

Using a novel ultrasonic technique, Andrew investigated the effect of feed-type on gastric emptying rates. While in Melbourne, he investigated the effect of breast milk fortifier on gastric emptying.

ii) Gastro-oesophageal reflux

He also investigated the relationship between delayed gastric emptying and gastro-oesophageal reflux using techniques developed within the department. He also supervised a project investigating methods of detecting reflux and the effect of body position on the severity of reflux.

Necrotising enterocolitis

Andrew has collaborated with Professor Janice Marshall in the Institute of Cardiovascular Sciences, University of Birmingham, over a number of years and developed a unique animal model for necrotising enterocolitis and devised a research protocol and grant applications in order to investigate the role of inflammatory mediators (particularly platelet-activating factor) in the aetiology of the disease. He co-supervised two PhD students who were involved in both in-vivo and in-vitro work using this model.

In a recent collaboration with a team from Bristol University, he has also been investigating faecal volatile organic compounds as a biomarker for NEC. This work successfully secured funding through an Action Medical Research project grant and Professor Ewer led the DOVE study, a multicentre trial which successfully recruited over 1,300 preterm babies.

Neonatal cardiology

In collaboration with the Cardiology Unit at Birmingham Children’s Hospital, Andrew has supervised four research fellows in neonatal cardiology. They have investigated postnatal outcomes for babies diagnosed with congenital heart disease and developed the technique of tissue Doppler assessment of neonatal myocardial function.

In collaboration with the University of Birmingham Clinical Trials Unit he secured HTA funding and undertook a multicentre trial examining the use of pulse oximetry as a screening procedure to detect congenital heart disease in newborn babies (PulseOx study).

Clinical trials

Andrew is a co-applicant on several NIHR-funded multicentre clinical trials including HOLDS, iHOLDS, CSTICH and CSTICH 2.

Andrew is an Honorary Consultant Neonatologist on the Regional Neonatal Unit at Birmingham Women’s Hospital delivering all aspects of clinical care to babies between birth and discharge from hospital.

Andrew is President Elect of the UK Neonatal Society.